Published in J Bone Miner Res on March 01, 1997
Unravelling the molecular control of calvarial suture fusion in children with craniosynostosis. BMC Genomics (2007) 1.18
The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal (2010) 1.16
In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol (2001) 0.95
Autologous stem cell regeneration in craniosynostosis. Bone (2007) 0.91
Paracrine interaction between adipose-derived stromal cells and cranial suture-derived mesenchymal cells. Plast Reconstr Surg (2010) 0.90
Transforming growth factor beta s and fibroblast growth factors and their receptors: role in sutural biology and craniosynostosis. J Bone Miner Res (1997) 0.84
Models of cranial suture biology. J Craniofac Surg (2012) 0.82
Differential growth factor adsorption to calvarial osteoblast-secreted extracellular matrices instructs osteoblastic behavior. PLoS One (2011) 0.81
Tissue interactions between craniosynostotic dura mater and bone. J Craniofac Surg (2012) 0.81
Comparison of craniofacial phenotype in craniosynostotic rabbits treated with anti-Tgf-beta2 at suturectomy site. Cleft Palate Craniofac J (2007) 0.79
Molecular basis of cranial suture biology and disease: Osteoblastic and osteoclastic perspectives. Genes Dis (2014) 0.77
Changes in biomechanical strain and morphology of rat calvarial sutures and bone after Tgf-β3 inhibition of posterior interfrontal suture fusion. Anat Rec (Hoboken) (2012) 0.77
Craniofacial surgery, from past pioneers to future promise. J Maxillofac Oral Surg (2010) 0.75
Absence of the sagittal suture does not result in scaphocephaly. Childs Nerv Syst (2012) 0.75
Signaling mechanisms implicated in cranial sutures pathophysiology: Craniosynostosis. BBA Clin (2016) 0.75
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol (1991) 3.38
Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem (1995) 3.30
The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07
Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A (1992) 2.89
Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology (1993) 2.86
Fibronectin: a review of its structure and biological activity. Mol Cell Biochem (1980) 2.85
Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J Biol Chem (1986) 2.61
Craniofacial tissue engineering by stem cells. J Dent Res (2006) 2.48
Spontaneous mutation and parental age in humans. Am J Hum Genet (1987) 2.37
Recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community. Health Serv Res (1995) 2.34
Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res (1992) 2.29
Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc Natl Acad Sci U S A (1985) 2.17
Successful repair in utero of a fetal diaphragmatic hernia after removal of herniated viscera from the left thorax. N Engl J Med (1990) 2.17
Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev (1993) 2.13
Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor beta. Immunohistochemical localization and association with differentiating cells. J Biol Chem (1986) 1.92
Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon. Gastroenterology (1993) 1.83
Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int (1996) 1.81
Which cholesterol level is related to the lowest mortality in a population with low mean cholesterol level: a 6.4-year follow-up study of 482,472 Korean men. Am J Epidemiol (2000) 1.79
Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med (1997) 1.75
Fetal hydrops and death from sacrococcygeal teratoma: rationale for fetal surgery. Am J Obstet Gynecol (1989) 1.74
Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-beta. J Biol Chem (1987) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther (2009) 1.63
Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse. J Invest Dermatol (1994) 1.59
Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59
Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg (1997) 1.59
Inducible repair of phosphotriesters in Escherichia coli. Proc Natl Acad Sci U S A (1983) 1.58
Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care (2001) 1.53
Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. Am J Pathol (1993) 1.52
Human NELL-1 expressed in unilateral coronal synostosis. J Bone Miner Res (1999) 1.52
Complete sequence analyses show that two defective interfering influenza viral RNAs contain a single internal deletion of a polymerase gene. Proc Natl Acad Sci U S A (1982) 1.52
Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg (2000) 1.51
Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg (1999) 1.51
TTF-1 and HNF-3beta in the developing tracheoesophageal fistula: further evidence for the respiratory origin of the distal esophagus'. J Pediatr Surg (1999) 1.50
Scarless wound repair: a human fetal skin model. Development (1992) 1.48
Home within 24 hours of laparoscopic hysterectomy. Aust N Z J Obstet Gynaecol (1999) 1.46
Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways. Proc Natl Acad Sci U S A (1991) 1.43
Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg (2000) 1.41
The role of groin dissection in the management of melanoma of the lower extremity. Ann Surg (1974) 1.39
ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood (2000) 1.38
Periorbital melanocytic lesions: excision and reconstruction in 40 patients. Plast Reconstr Surg (1998) 1.38
Craniofacial shortening by contraction osteogenesis: an experimental model. Plast Reconstr Surg (2000) 1.38
Pulmonary vascular resistance in neonatal swine: response to right pulmonary artery occlusion, isoproterenol, and prostaglandin E1. J Pediatr Surg (1990) 1.38
Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol (2000) 1.38
The three-dimensional cephalogram: theory, technique, and clinical application. Am J Orthod Dentofacial Orthop (1988) 1.37
The "back to sleep campaign" and deformational plagiocephaly: is there cause for concern? J Craniofac Surg (1996) 1.36
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg (1999) 1.34
Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J Cell Physiol (1993) 1.34
VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physiol Cell Physiol (2000) 1.33
Body mass index and mortality: a twelve-year prospective study in Korea. Epidemiology (2001) 1.33
Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta. Am J Pathol (1994) 1.32
Histologic study of artificial skin used in the treatment of full-thickness thermal injury. J Burn Care Rehabil (1990) 1.32
Congenital infiltrating lipomatosis of the face: clinicopathologic evaluation and treatment. Plast Reconstr Surg (1983) 1.32
Scar formation: the spectral nature of fetal and adult wound repair. Plast Reconstr Surg (1996) 1.31
Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg (2001) 1.30
Congenital muscular torticollis and the associated craniofacial changes. Plast Reconstr Surg (2000) 1.29
Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol (1995) 1.27
Binding of transforming growth factor-beta to cell surface proteins varies with cell type. Mol Endocrinol (1989) 1.27
Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor. J Immunol (1993) 1.27
Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Am J Surg (1999) 1.27
Effects of electromagnetic stimuli on bone and bone cells in vitro: inhibition of responses to parathyroid hormone by low-energy low-frequency fields. Proc Natl Acad Sci U S A (1982) 1.26
Rapid epithelialisation of fetal wounds is associated with the early deposition of tenascin. J Cell Sci (1991) 1.26
Scarless fetal healing. Therapeutic implications. Ann Surg (1992) 1.25
Fetal intervention in obstructive uropathy: prognostic indicators and efficacy of intervention. Am J Obstet Gynecol (1990) 1.24
Expression of transforming growth factor-beta 1, -beta 2, and -beta 3 mRNA and protein in the murine lung. Am J Respir Cell Mol Biol (1991) 1.23
Membrane binding characteristics of two forms of transforming growth factor-beta. J Biol Chem (1987) 1.22
Proteolytic control of growth factor availability. APMIS (1999) 1.21
Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (1995) 1.21
Osteogenesis in cranial defects: reassessment of the concept of critical size and the expression of TGF-beta isoforms. Plast Reconstr Surg (2000) 1.20
Reduced expression of PDGF and PDGF receptors during impaired wound healing. J Invest Dermatol (1997) 1.20
Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg (1999) 1.19
Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations. Cancer Res (1998) 1.19
Fibronectin-collagen binding and requirement during cellular adhesion. Biochem J (1980) 1.19
The effects of ionizing radiation on osteoblast-like cells in vitro. Plast Reconstr Surg (2000) 1.18
Early experience with open fetal surgery for congenital hydronephrosis. J Pediatr Surg (1988) 1.17
Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1. Cancer Chemother Pharmacol (2001) 1.17
High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev (1995) 1.16
Etiology of intestinal damage in gastroschisis. I: Effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg (1989) 1.14
Biochemical and immunological characterization of three binding sites on human plasma fibronectin with different affinities for heparin. Biochemistry (1983) 1.14
Fetal wound healing. The ontogeny of scar formation in the non-human primate. Ann Surg (1993) 1.14
Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A (1995) 1.13
Volumetric quantification of intracranial and ventricular volume following cranial vault remodeling: a preliminary report. Plast Reconstr Surg (1987) 1.13
Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol (1998) 1.13
Limited cleavage of cellular fibronectin by plasminogen activator purified from transformed cells. Proc Natl Acad Sci U S A (1987) 1.13
Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. Diabetes (1993) 1.12
Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem (1989) 1.12
Mesenchymal cells for skeletal tissue engineering. Panminerva Med (2009) 1.12
Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med (1987) 1.11
Membranous bone lengthening: a serial histological study. Ann Plast Surg (1992) 1.11
Fitness, fatness and activity as predictors of bone mineral density in older persons. J Intern Med (2002) 1.11
New developments in cranial suture research. Plast Reconstr Surg (2001) 1.10
Etiology of intestinal damage in gastroschisis, II. Timing and reversibility of histological changes, mucosal function, and contractility. J Pediatr Surg (1990) 1.08
Auricular reconstruction: indications for autogenous and prosthetic techniques. Plast Reconstr Surg (2001) 1.08
Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection. J Clin Invest (1996) 1.08
Biomolecular mechanisms of calvarial bone induction: immature versus mature dura mater. Plast Reconstr Surg (2000) 1.08